Public Health Foundation Enterprises, Inc.   Report issue

Foundation Phase 2 Phase 4
Founded: City of Industry CA United States (1969)

Organization Overview

First Clinical Trial
2006
NCT00318409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Public Health Foundation Enterprises, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

emtricitabine (emtriva) (3 trials)

tenofovir (viread) (4 trials)

Drugs in Phase 2 Trials (2)

bupropion (wellbutrin) (1 trial)

mirtazapine (remeron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Substance-Related Disorders (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 4